Home

Adaptado Hija Retirarse vas narasimhan novartis mirar televisión Pautas Monótono

The 'student' of leadership who seeks to inspire his employees | Financial  Times
The 'student' of leadership who seeks to inspire his employees | Financial Times

Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint
Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint

The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED

Un médico para Novartis | Economía | EL PAÍS
Un médico para Novartis | Economía | EL PAÍS

Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis's Vas Narasimhan on AI, Data Science for Company Operations

Interview: Vas Narasimhan, the 'unboss' of Novartis
Interview: Vas Narasimhan, the 'unboss' of Novartis

Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Vasant Narasimhan: Nuevos despidos
Vasant Narasimhan: Nuevos despidos

Basel is very open to newcomers - Basel Area Business & Innovation
Basel is very open to newcomers - Basel Area Business & Innovation

Vasant Narasimhan | Novartis
Vasant Narasimhan | Novartis

Novartis prevé destinar más de 8.800 millones a la compra de otras empresas  en 2019 | PlantaDoce
Novartis prevé destinar más de 8.800 millones a la compra de otras empresas en 2019 | PlantaDoce

Vas Narasimhan, chief executive officer of Novartis AG, reacts during...  Fotografía de noticias - Getty Images
Vas Narasimhan, chief executive officer of Novartis AG, reacts during... Fotografía de noticias - Getty Images

There's an explosion of data & digital opportunities in Indian healthcare: Vasant  Narasimhan, CEO, Novartis - The Economic Times
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times

Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos

Performance slump takes toll on Novartis' CEO's 2022 payout
Performance slump takes toll on Novartis' CEO's 2022 payout

Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Vas Narasimhan: the American trying to reshape Novartis | Financial Times

Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint
Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint

El CEO de Novartis advierte: una vacuna no bastará para combatir el COVID -  Infobae
El CEO de Novartis advierte: una vacuna no bastará para combatir el COVID - Infobae

Meet our people: Vas Narasimhan - YouTube
Meet our people: Vas Narasimhan - YouTube

Transforming Standards Of Patient Care And Unbossing The Organisation With  Novartis CEO Vas Narasimhan - Outside Lens
Transforming Standards Of Patient Care And Unbossing The Organisation With Novartis CEO Vas Narasimhan - Outside Lens

Vasant Narasimhan | Longevity Industry in Switzerland Landscape |  RadialReport
Vasant Narasimhan | Longevity Industry in Switzerland Landscape | RadialReport

Vas Narasimhan (@VasNarasimhan) / Twitter
Vas Narasimhan (@VasNarasimhan) / Twitter

Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en  Gambia a dirigir un gigante farmacéutico | Líderes
Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en Gambia a dirigir un gigante farmacéutico | Líderes